Norris Medicines Statistics

Total Valuation

BOM:524414 has a market cap or net worth of INR 179.91 million. The enterprise value is 395.32 million.

Market Cap	179.91M
Enterprise Value	395.32M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:524414 has 10.00 million shares outstanding. The number of shares has decreased by -0.21% in one year.

Current Share Class	10.00M
Shares Outstanding	10.00M
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	24.00%
Owned by Institutions (%)	1.50%
Float	2.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.09
PB Ratio	-1.21
P/TBV Ratio	n/a
P/FCF Ratio	64.37
P/OCF Ratio	60.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-31.95
EV / Sales	6.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	141.44

Financial Position

The company has a current ratio of 0.62

Current Ratio	0.62
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	77.21
Interest Coverage	-1.82

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-3.57%
Return on Invested Capital (ROIC)	-6.84%
Return on Capital Employed (ROCE)	-21.85%
Revenue Per Employee	1.29M
Profits Per Employee	-275,000
Employee Count	45
Asset Turnover	0.42
Inventory Turnover	0.82

Taxes

In the past 12 months, BOM:524414 has paid 594,000 in taxes.

Income Tax	594,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.39% in the last 52 weeks. The beta is -0.25, so BOM:524414's price volatility has been lower than the market average.

Beta (5Y)	-0.25
52-Week Price Change	+15.39%
50-Day Moving Average	18.43
200-Day Moving Average	19.20
Relative Strength Index (RSI)	46.41
Average Volume (20 Days)	986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524414 had revenue of INR 58.20 million and -12.38 million in losses. Loss per share was -1.24.

Revenue	58.20M
Gross Profit	23.69M
Operating Income	-8.00M
Pretax Income	-11.78M
Net Income	-12.38M
EBITDA	-2.63M
EBIT	-8.00M
Loss Per Share	-1.24

Full Income Statement

Balance Sheet

The company has 398,000 in cash and 215.81 million in debt, giving a net cash position of -215.41 million or -21.54 per share.

Cash & Cash Equivalents	398,000
Total Debt	215.81M
Net Cash	-215.41M
Net Cash Per Share	-21.54
Equity (Book Value)	-148.68M
Book Value Per Share	-14.97
Working Capital	-38.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.99 million and capital expenditures -190,000, giving a free cash flow of 2.80 million.

Operating Cash Flow	2.99M
Capital Expenditures	-190,000
Free Cash Flow	2.80M
FCF Per Share	0.28

Full Cash Flow Statement

Margins

Gross margin is 40.70%, with operating and profit margins of -13.74% and -21.26%.

Gross Margin	40.70%
Operating Margin	-13.74%
Pretax Margin	-20.24%
Profit Margin	-21.26%
EBITDA Margin	-4.52%
EBIT Margin	-13.74%
FCF Margin	4.80%

Dividends & Yields

BOM:524414 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.21%
Shareholder Yield	n/a
Earnings Yield	-6.88%
FCF Yield	1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 22, 2013. It was a reverse split with a ratio of 0.3000003.

Last Split Date	Aug 22, 2013
Split Type	Reverse
Split Ratio	0.3000003

Scores

BOM:524414 has an Altman Z-Score of -2.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.26
Piotroski F-Score	4